港股异动|中国奥园涨近5%中期纯利同比增长86.8%
格隆汇8月19日丨中国奥园(3883.HK)现报9.97港元,涨4.95%,暂成交3233万港元,最新总市值268.23亿港元。中国奥园上周五(16日)晚间发布中期业绩公告称,期内实现营业额236.7亿元(人民币,下同),同比增长73%;毛利润70.5亿元,同比增长81%;毛利润率由28.6%增至29.8%;公司拥有人应占利润22.72亿元,同比增长86.8%;基本每股收益84.81分。此外,于今年上半年,新增总建筑面积约726万平方米,期内合同销售额536.3亿元,同比上升33%,其中来自华南区域城市贡献合同销售约228.2亿元,约占总合同销售的42%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.